TY - JOUR
T1 - Applying 'omics technologies in chemicals risk assessment
T2 - Report of an ECETOC workshop
AU - Buesen, Roland
AU - Chorley, Brian N.
AU - da Silva Lima, Beatriz
AU - Daston, George
AU - Deferme, Lize
AU - Ebbels, Timothy
AU - Gant, Timothy W.
AU - Goetz, Amber
AU - Greally, John
AU - Gribaldo, Laura
AU - Hackermüller, Jörg
AU - Hubesch, Bruno
AU - Jennen, Danyel
AU - Johnson, Kamin
AU - Kanno, Jun
AU - Kauffmann, Hans Martin
AU - Laffont, Madeleine
AU - McMullen, Patrick
AU - Meehan, Richard
AU - Pemberton, Mark
AU - Perdichizzi, Stefania
AU - Piersma, Aldert H.
AU - Sauer, Ursula G.
AU - Schmidt, Kerstin
AU - Seitz, Hervé
AU - Sumida, Kayo
AU - Tollefsen, Knut E.
AU - Tong, Weida
AU - Tralau, Tewes
AU - van Ravenzwaay, Ben
AU - Weber, Ralf J.M.
AU - Worth, Andrew
AU - Yauk, Carole
AU - Poole, Alan
N1 - Funding Information:
The content described in this article has been reviewed by the National Health and Environmental Research Laboratory of the U.S. Environmental Protection Agency and approved for publication. Approval does not signify that the contents necessarily reflect the views and the policies of the Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The views presented in this article do not necessarily reflect current or future opinion or policy of the U.S. Food and Drug Administration. Any mention of commercial products is for clarification and not intended as an endorsement. LG and AW are staff members of the Commission. The opinions expressed are those of the authors and do not necessarily reflect the official views of the European Commission.
Publisher Copyright:
© 2017
PY - 2017/12
Y1 - 2017/12
N2 - Prevailing knowledge gaps in linking specific molecular changes to apical outcomes and methodological uncertainties in the generation, storage, processing, and interpretation of 'omics data limit the application of 'omics technologies in regulatory toxicology. Against this background, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) convened a workshop Applying 'omics technologies in chemicals risk assessment that is reported herein. Ahead of the workshop, multi-expert teams drafted frameworks on best practices for (i) a Good-Laboratory Practice-like context for collecting, storing and curating 'omics data; (ii) the processing of 'omics data; and (iii) weight-of-evidence approaches for integrating 'omics data. The workshop participants confirmed the relevance of these Frameworks to facilitate the regulatory applicability and use of 'omics data, and the workshop discussions provided input for their further elaboration. Additionally, the key objective (iv) to establish approaches to connect 'omics perturbations to phenotypic alterations was addressed. Generally, it was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways. While further work is necessary before gene expression changes can be used to establish safe levels of substance exposure, the ECETOC workshop provided important incentives towards achieving this goal.
AB - Prevailing knowledge gaps in linking specific molecular changes to apical outcomes and methodological uncertainties in the generation, storage, processing, and interpretation of 'omics data limit the application of 'omics technologies in regulatory toxicology. Against this background, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) convened a workshop Applying 'omics technologies in chemicals risk assessment that is reported herein. Ahead of the workshop, multi-expert teams drafted frameworks on best practices for (i) a Good-Laboratory Practice-like context for collecting, storing and curating 'omics data; (ii) the processing of 'omics data; and (iii) weight-of-evidence approaches for integrating 'omics data. The workshop participants confirmed the relevance of these Frameworks to facilitate the regulatory applicability and use of 'omics data, and the workshop discussions provided input for their further elaboration. Additionally, the key objective (iv) to establish approaches to connect 'omics perturbations to phenotypic alterations was addressed. Generally, it was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways. While further work is necessary before gene expression changes can be used to establish safe levels of substance exposure, the ECETOC workshop provided important incentives towards achieving this goal.
KW - Adverse outcome pathway (AOP)
KW - Differentially expressed genes
KW - Gene expression
KW - Good laboratory practice (GLP)
KW - Metabolomics
KW - Mode-of-action (MoA)
KW - Regulatory toxicology
KW - Transcriptomics
KW - Weight-of-evidence (WoE)
UR - http://www.scopus.com/inward/record.url?scp=85030780550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030780550&partnerID=8YFLogxK
U2 - 10.1016/j.yrtph.2017.09.002
DO - 10.1016/j.yrtph.2017.09.002
M3 - Article
C2 - 28958911
AN - SCOPUS:85030780550
SN - 0273-2300
VL - 91
SP - S3-S13
JO - Regulatory Toxicology and Pharmacology
JF - Regulatory Toxicology and Pharmacology
ER -